Key Record Dates
ClinicalTrials.gov Identifier: | NCT02048813 |
---|---|
Brief Title: | Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma |
First Submitted : | January 27, 2014 |
First Submitted that Met QC Criteria : | January 27, 2014 |
First Posted : | January 29, 2014 (Estimate) |
Last Update Submitted that Met QC Criteria : | November 22, 2019 |
Last Update Posted : | November 25, 2019 |